Seán Canney TD, Minister of State for International and Road Transport, Logistics, Rail and Ports and Leader in Cabinet of the Independent Ministers, has welcomed today’s announcement of €39 million in new awards under Call 7 of the Disruptive Technologies Innovation Fund (DTIF) – confirming that more than €26.3 million of this funding is linked to projects involving Galway companies and the University of Galway.

This latest round brings total Call 7 funding to a record €159 million, supporting breakthrough innovations in MedTech, AI and advanced healthcare.

Minister Canney said the scale of Galway’s involvement reflects the region’s established leadership in life sciences, medical devices and research excellence: “I am very pleased to see Galway so strongly represented in these DTIF awards. University of Galway and several Galway-based innovators are central partners in high-impact projects that will transform healthcare and support new jobs and enterprise growth in the West. This is a major endorsement of the talent and capability within our region.”

Galway-linked projects announced today include:

  • PIONEER (€7.2m) – Advanced immuno-oncology and pathology project involving University of Galway alongside Galway based company Mirai Medical and other Dublin based institutions.
  • RECAP (€6.6m) – Developing treatments for chronic musculoskeletal pain, involving Galway based CrannMed, University of Galway and Kerry and Dublin companies and institutions.
  • HealAsystant (€6.3m) – AI-assisted self-management support system for compression therapy involving Galway company FeelTect, University of Galway and Cork based companies.
  • SmartMobility CNM (€3.3m) – Continuous nutritional monitoring technology involving Galway companies Rockfield Medical Devices, Invermed Teo and Dublin based companies.
  • PerQHern (€2.9m) – A minimally invasive percutaneous hernia repair solution involving Galway company Aran Biomedical and Dublin and Sligo companies.

Minister Canney said these projects will deliver long-term benefits: “These collaborations between Galway industry and our universities are tackling major health challenges – from cancer screening to chronic pain, wound care and advanced medical devices. This investment strengthens Galway’s position as a global MedTech hub and ensures the West continues to lead in disruptive innovation.”

DTIF is a €500 million fund under the National Development Plan that accelerates collaboration between enterprise and research institutions to commercialise disruptive technologies with global potential.